Symmetric binary polymer blends confined in thin films between competing walls: Interplay between finite size and wetting behavior

Literature Information

Publication Date 2001-02-13
DOI 10.1039/B008627O
Impact Factor 3.676
Authors

E. V. Albano


View Original

Abstract

The phase behavior and structure of a symmetric binary polymer blend confined between two hard impenetrable walls is studied, assuming also short range forces between the monomers and the walls. Phenomenological considerations are elaborated with the self-consistent field theory of Gaussian chains, and also some Monte Carlo simulations of the bond-fluctuation model. In the case of “antisymmetric” walls (right wall attracts component A with the same strength as does left wall component B) the phase diagram is symmetric around volume fraction ϕ = 1/2. For very thin films (or very weak surface fields) one finds a single critical point at ϕc = 1/2, as in the bulk. For thicker films, or stronger surface fields, the phase diagram exhibits two critical points and two concomitant coexistence regions, down to a triple point Tt, while below the triple point there is a single coexistence region. When the film thickness D → ∞, the two coexistence regions for T>Tt shrink into the prewetting lines, while Tt approaches the wetting transition temperature. Asymmetric surface forces are also considered, studying the smooth crossover from “ antisymmetric walls” to “ symmetric walls” (that both attract the A component with the same strength). The resulting crossover between capillary-type behavior (i.e., a single critical point of the thin film) and the above behavior with two critical points is analyzed. Particular attention is paid to the behavior of interfaces between coexisting phases.

Related Literature

Back cover

Other

DOI: 10.1039/CS98312BX007

Back cover

Other

DOI: 10.1039/CS99019BX003

Corrigenda

Other

DOI: 10.1039/CS980090X011

Front cover

Other

DOI: 10.1039/CS99019FX001

Front cover

Other

DOI: 10.1039/CS98009FX001

Back cover

Other

DOI: 10.1039/CS98009BX007

Front cover

Other

DOI: 10.1039/CS98312FX001

Back matter

Other

DOI: 10.1039/CS99120BP015

Contents pages

Other

DOI: 10.1039/CS99019FP007

Back cover

Other

DOI: 10.1039/CS98514BX015

You might also like

Compound Q&A

What are the main uses of (3.beta.)-3-Hydroxy-N,N-dimethyl-chol-5-en-24-amide (CAS: 79066-03-8)?

(3.beta.)-3-Hydroxy-N,N-dimethyl-chol-5-en-24-amide (CAS: 79066-03-8) is primari...

79066-03-8(3.beta.)-3-Hydroxy-...
Compound Q&A

What regulatory guidelines apply to 5-(aminomethyl)-2-methoxyphenol (CAS: 89702-89-6)?

5-(Aminomethyl)-2-methoxyphenol (CAS: 89702-89-6) is classified under GHS as a s...

89702-89-65-(aminomethyl)-2-me...
Compound Q&A

What is Thieno[2,3-c]pyridin-7(6H)-one (CAS: 28981-13-7)?

Thieno[2,3-c]pyridin-7(6H)-one (CAS: 28981-13-7) is a heterocyclic organic compo...

28981-13-7Thieno[2,3-c]pyridin...
Compound Q&A

Is 1-[(6-Methoxy-3-pyridinyl)methyl]-4-piperidinamine dihydrochloride (CAS: 1185311-28-7) safe?

1-[(6-Methoxy-3-pyridinyl)methyl]-4-piperidinamine dihydrochloride is generally ...

1185311-28-71-[(6-Methoxy-3-pyri...
Compound Q&A

What regulatory guidelines apply to [(2E)-3-Phenyl-2-propen-1-yl]phosphonic acid (CAS: 146404-58-2)?

[(2E)-3-Phenyl-2-propen-1-yl]phosphonic acid (CAS: 146404-58-2) is regulated und...

146404-58-2[(2E)-3-Phenyl-2-pro...
Compound Q&A

What regulatory guidelines apply to 6-Bromo-7-methoxyquinoline (CAS: 1620515-86-7)?

6-Bromo-7-methoxyquinoline (CAS: 1620515-86-7) falls under the scope of the Glob...

1620515-86-76-Bromo-7-methoxyqui...
Compound Q&A

What industries use (2R)-1-(1-Benzofuran-2-yl)-N-propyl-2-pentanamine (CAS: 260550-89-8)?

This compound is primarily used in the pharmaceutical industry for the developme...

260550-89-8(2R)-1-(1-Benzofuran...
1228013-15-71-Ethyl-7-[2-methyl-...
Compound Q&A

Are there alternatives to {5-(Acryloylamino)-2-[(dimethylamino)methyl]phenyl}boronic acid (CAS: 1217500-78-1) in synthesis?

Alternative reagents such as 2-[(dimethylamino)methyl]phenylboronic acid or rela...

1217500-78-1{5-(Acryloylamino)-2...
Compound Q&A

What is 3-(Piperidin-4-yloxy)pyridine (CAS: 310881-48-2)?

3-(Piperidin-4-yloxy)pyridine (CAS: 310881-48-2) is an organic compound with the...

310881-48-23-(Piperidin-4-yloxy...

Source Journal

Physical Chemistry Chemical Physics

Physical Chemistry Chemical Physics
CiteScore: 5.5
Self-citation Rate: 10.3%
Articles per Year: 3036

Physical Chemistry Chemical Physics (PCCP) is an international journal co-owned by 19 physical chemistry and physics societies from around the world. This journal publishes original, cutting-edge research in physical chemistry, chemical physics and biophysical chemistry. To be suitable for publication in PCCP, articles must include significant innovation and/or insight into physical chemistry; this is the most important criterion that reviewers and Editors will judge against when evaluating submissions. The journal has a broad scope and welcomes contributions spanning experiment, theory, computation and data science. Topical coverage includes spectroscopy, dynamics, kinetics, statistical mechanics, thermodynamics, electrochemistry, catalysis, surface science, quantum mechanics, quantum computing and machine learning. Interdisciplinary research areas such as polymers and soft matter, materials, nanoscience, energy, surfaces/interfaces, and biophysical chemistry are welcomed if they demonstrate significant innovation and/or insight into physical chemistry. Joined experimental/theoretical studies are particularly appreciated when complementary and based on up-to-date approaches.

Recommended Compounds

Recommended Suppliers

Disclaimer
This page provides academic journal information for reference and research purposes only. We are not affiliated with any journal publishers and do not handle publication submissions. For publication-related inquiries, please contact the respective journal publishers directly.
If you notice any inaccuracies in the information displayed, please contact us at support@chemtradehub.com. We will promptly review and address your concerns.